During the past decade, Universitatsklinikum Ulm, Klinik fur Innere Medizin II conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitatsklinikum Ulm, Klinik fur Innere Medizin II" #1 collaborator was "Janssen Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Universitatsklinikum Ulm, Klinik fur Innere Medizin II" are "Crohn Disease" (2 trials), "Mantle Cell Lymphoma" (1 trials) and "Ulcerative Colitis" (1 trials). Many other conditions were trialed in "Universitatsklinikum Ulm, Klinik fur Innere Medizin II" in a lesser frequency.

Most popular intervention types in "Universitatsklinikum Ulm, Klinik fur Innere Medizin II" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "JNJ-67864238" (1 trials), "PCI-32765" (1 trials), "Placebo" (1 trials), "Placebo (IV)" (1 trials) and "Placebo (SC)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitatsklinikum Ulm, Klinik fur Innere Medizin II" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Universitatsklinikum Ulm, Klinik fur Innere Medizin II". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Universitatsklinikum Ulm, Klinik fur Innere Medizin II, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Universitatsklinikum Ulm, Klinik fur Innere Medizin II, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".